openPR Logo
Press release

Global Psoriasis Drugs Market is predicted to progress at a CAGR of 6.5% to reach US$ 21.48 Bn by 2031

02-03-2023 04:45 AM CET | Health & Medicine

Press release from: Persistence Market Research

Global Psoriasis Drugs Market is predicted to progress at a CAGR

Psoriasis is a skin disorder that affects more than 125 million people worldwide, causing painful, itchy patches on the skin. While there is no one-size-fits-all cure for this condition, there are many treatments available including topical medications, light therapy and biologic agents.

Among these treatments, psoriasis drugs have become increasingly popular as they work to reduce inflammation and slow down the production of skin cells. For example, some psoriasis medications block certain enzymes or hormones involved in the immune response which helps to prevent further damage from occurring. Additionally, drugs such as cyclosporine can be used to decrease inflammation while phototherapy can help reduce itching, redness and irritation.

Request For Free Sample Report of "Psoriasis Drugs Market"@ https://www.persistencemarketresearch.com/samples/25102

Psoriasis is a chronic inflammatory skin disease that occurs due to genetic disposition and environmental factors. Psoriasis is a systemic disease associated with psychological, metabolic, arthritic, and cardiovascular comorbidities. On an average, psoriasis affects around 2 - 3% of the population globally.

Plaque psoriasis, being the number one and most common indication, held nearly 85% share of the US$ 11.37 Bn psoriasis drugs market in 2021, with the market estimated to expand at a CAGR of nearly 6.5% over the next ten years.

An array of agents exist for the symptomatic treatment of psoriasis. Patients with mild-to-moderate psoriasis typically receive topical treatments that modulate gene transcription, promote keratinocyte differentiation, and inhibit cell proliferation.

A number of innovative and advanced therapies for the treatment and management of psoriasis are under development, many of which have novel targets and mechanisms of action. Psoriasis is linked with a number of medical conditions inclusive of psoriatic arthritis, depression, and cardio metabolic syndrome. The most commonly occurring form of psoriasis is chronic plaque.

Key Takeaways from Market Study

Topical products are expected to continue holding over one-third market value share through 2031, primarily because of clinically approved topical ointments, foams, and creams available for the management of inflammation and rash due to psoriasis.
Efficiency of corticosteroids for skin irritability and inflammation makes corticosteroid the leading segment with over 34% of revenue share in 2021.
Easy availability of psoriasis drugs in hospital pharmacies and large distribution networks of hospital chains make it the largest segment, with more than 39% market share.
Plaque psoriasis is the most commonly occurring autoimmune disease, accounting for a revenue share of around 85% in 2021.
Presence of a large number of manufacturers, rising public awareness, and easy availability of psoriasis drugs and treatment options make North America the leading regional market with over 27% market share in 2021.
"Growing adoption of combination therapy and favourable reimbursement support for psoriasis to drive market growth," says an analyst of Persistence Market Research.

Buy Full Report Now @ https://www.persistencemarketresearch.com/checkout/25102

Market Competition

Companies such as Amgen and Sun Pharma have been strongly working toward the development of an extensive clinical pipeline and manufacturing of new product lines for the treatment of psoriasis.

In December 2021, Amgen announced positive top-line results from the Otezla® (apremilast) Phase 3 DISCREET study in moderate to severe genital psoriasis.
In September 2020, Sun Pharma announced the launch of ILUMYA® (tildrakizumab) for the treatment of plaque psoriasis, in Japan.
Similarly, other psoriasis drug manufacturers are also trying to maintain and strengthen their portfolios through collaborations with local players or distribution partners. All such recent developments related to companies manufacturing psoriasis drugs have been tracked by the team at Persistence Market Research, which are available in the full report.

Key companies operating in the psoriasis drugs market include Janssen Biotech Inc, Novartis International Ltd., Amgen Inc, Pfizer Inc., Takeda Pharmaceutical Company Ltd. Merck & Co, Inc., Abb Vie Inc., Eli Lilly and Company, Boehringer Ingelheim GmbH, and Sun Pharmaceutical Industries Ltd.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the psoriasis drugs market in its latest study, presenting historical demand assessment of 2016 - 2021 and projections for 2022 - 2031.

The research study is based on the product (topical, oral, and injectable), drug class (interleukin inhibitors, corticosteroids, anti-inflammatory, and tumor necrosis factor inhibitor), distribution channel (hospital pharmacies, retail pharmacies, and e-Commerce), and indication (guttate psoriasis, inverse psoriasis, pustular psoriasis, erythrodermic psoriasis, and plaque psoriasis), across seven key regions of the world.

Request Customization @ https://www.persistencemarketresearch.com/request-customization/25102

Key Questions Answered in This Report.

What are the Roadblocks for Psoriasis Drugs Market Suppliers?
What are the Key Opportunities for Psoriasis Drugs Market Manufacturers?
How is Focus on Safety Influencing Psoriasis Drugs Market Demand?
What is the Regulatory Impact on Global Sales of Psoriasis Drugs Market?
Which Region Offers the Largest Opportunity for Sales of Psoriasis Drugs Market?
Where Does the U.S. Stand in the Market for Psoriasis Drugs Market?
What Is the Outlook for Psoriasis Drugs Market Manufacturers in China?
Why is Germany a Lucrative Market for Psoriasis Drugs Market Manufacturers?
Why Will Belgium Outpace Other European Markets for Psoriasis Drugs Market?
Why is There High Demand for Tires in Psoriasis Drugs Market?
Why are Sales of Psoriasis Drugs Market Surging?

For More Premium Insights, Check out the Link:

Functional Brain Imaging Systems Market - https://www.prnewswire.com/news-releases/functional-brain-imaging-systems-market-is-set-to-experience-a-significant-6-3-cagr-from-2021-to-2031---persistence-market-research-301484724.html

Mri Systems Market - https://www.prnewswire.com/news-releases/mri-systems-market-is-expected-to-register-a-cagr-of-6-5-over-the-forecast-period-2021-2031---persistence-market-research-301484669.html

Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com

About Us

Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Psoriasis Drugs Market is predicted to progress at a CAGR of 6.5% to reach US$ 21.48 Bn by 2031 here

News-ID: 2911435 • Views:

More Releases from Persistence Market Research

Frozen Foods Market Heats Up with Innovation and Growing Consumer Demand
Frozen Foods Market Heats Up with Innovation and Growing Consumer Demand
Market Overview: The frozen foods market consists of a wide range of products, including frozen fruits and vegetables, meat and seafood, ready-to-eat meals, and desserts. These products are preserved through freezing to maintain freshness and quality for an extended period. Market Size and Growth: The global market for frozen foods is forecasted to be of valuation US$ 281.0 Billion in the year 2022 which is expanding at a value CAGR of 5.1% and
The Global Graphene Market's Striking Growth and Innovative Applications
The Global Graphene Market's Striking Growth and Innovative Applications
Introduction Graphene, a single layer of carbon atoms arranged in a hexagonal lattice, has gained global recognition for its extraordinary properties, such as exceptional electrical and thermal conductivity, mechanical strength, and flexibility. Since its isolation in 2004 by Andre Geim and Konstantin Novoselov, graphene has sparked considerable interest in both scientific and industrial communities. This report explores the current state of the graphene market and its potential growth opportunities. Get Access To
Business Opportunities in Cyber Security Mesh Market : Top Countries Data Analysis, Emerging Trends with Upcoming Developments
Business Opportunities in Cyber Security Mesh Market : Top Countries Data Analys …
Market Overview: The projected global market size for cyber security mesh is expected to reach $8.8 billion by the year 2033, with an estimated valuation of $1.2 billion by 2023. This market is poised to experience a compound annual growth rate (CAGR) of 21.7% from 2023 to 2033. The global Cyber Security Mesh market is poised for significant growth as organizations worldwide grapple with the escalating threat landscape. Cybersecurity has become an
Synthetic Beta-Carotene Market To Boost Incredible Growth: 2033, Share Valuation and Industry Size
Synthetic Beta-Carotene Market To Boost Incredible Growth: 2033, Share Valuation …
Key market trends included a shift towards natural and plant-based ingredients, as consumers sought cleaner labels and healthier options. This drove the demand for naturally sourced beta-carotene, but synthetic beta-carotene still had its place due to its cost-effectiveness and consistency in production. The market was also influenced by regulatory changes and evolving dietary preferences, which affected the application and formulation of synthetic beta-carotene in various products. To obtain the latest market

All 5 Releases


More Releases for Psoriasis

Psoriasis Treatment Market for Acne and Psoriasis in North America and Europe: H …
A new research report highlighting the advances made in phototherapy treatment in North America and Europe has been added to the repository of Market Research Hub (MRH). The report titled “Phototherapy Treatment Market for Acne and Psoriasis: North America and Europe Industry Analysis 2012 - 2016 and Opportunity Assessment 2017 – 2027” offers detailed insights and analysis on the key factors impacting the growth of the phototherapy treatment market for acne
Technological Advancements Of Psoriasis Market with Focus on Plaque Psoriasis 20 …
Albany, NY, 16th November : Recent research and the current scenario as well as future market potential of "Global Psoriasis Market with Focus on Plaque Psoriasis: Outlook to 2020" globally. Psoriasis is a chronic inflammatory skin disease primarily causing scaling and inflammation of skin, characterized by sharply demarcated, scaly, red skin lesions most often on the elbows, knees, scalps, hands and feet. Get PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=748522 It
Global Psoriasis Industrial and Market Analysis with Focus on Plaque Psoriasis: …
"Global Psoriasis Market with Focus on Plaque Psoriasis: Outlook to 2020" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. Description- Psoriasis is a chronic inflammatory skin disease primarily causing scaling and inflammation of skin, characterized by sharply demarcated, scaly, red skin lesions most often on the elbows, knees, scalps, hands and feet. It occurs when the body’s immune system sends out faulty signals that speed
Psoriasis Treatment Market: Analysis & Trends 2024
Global Psoriasis Treatment Market - Overview This report on the Psoriasis Treatment market analyzes the current and future scenario of the global market. Approval of new biologics, increase in access for the treatment in developing market, increase in the number of psoriasis patients, are boosting the growth of the global Psoriasis Treatment market. Increase in the incidence of Psoriasis and skin disorders, and novel pipeline drugs are some of the factors
Psoriasis - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Psoriasis - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Psoriasis - Pipeline Review, H1 2017, provides an overview of the Psoriasis (Immunology) pipeline landscape. Psoriasis is a chronic skin condition caused by an overactive immune system. Symptoms of the disease include shedding of cells, flared up
Global Psoriasis Market with Focus on Plaque Psoriasis: Outlook to 2020
Psoriasis is a chronic inflammatory skin disease primarily causing scaling and inflammation of skin, characterized by sharply demarcated, scaly, red skin lesions most often on the elbows, knees, scalps, hands and feet. It occurs when the body’s immune system sends out faulty signals that speed up the growth cycle of skin cells. Psoriasis has been majorly classified into Plaque psoriasis, Guttate psoriasis, Inverse psoriasis, Pustular psoriasis and Erytherodermic psoriasis. It